Treatment of advanced gastric cancer with etoposide, folinic acid, and fluorouracil in the clinical setting: efficacy of therapy and value of serum tumor markers.

scientific article published in January 2002

Treatment of advanced gastric cancer with etoposide, folinic acid, and fluorouracil in the clinical setting: efficacy of therapy and value of serum tumor markers. is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1028043393
P356DOI10.1385/MO:19:1:43
P698PubMed publication ID12025890

P50authorWolfgang StremmelQ50772068
P2093author name stringAndreas Teufel
Henning Schulze-Bergkamen
Ivan Zuna
Jochen Rudi
P2860cites workReporting results of cancer treatmentQ29620070
Cisplatin, mitomycin-C, 5-fluorouracil and leucovorin combination chemotherapy (l-FCM) in locally advanced unresectable or metastatic gastric carcinoma: a phase-II study.Q31687917
Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative GrouQ33388301
Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancerQ33428767
Prognostic significance of CEA, CA 19-9 and CA 72-4 preoperative serum levels in gastric carcinoma.Q34504094
Chemotherapy of carcinoma of the stomachQ40875195
The treatment of advanced gastric cancerQ40938936
New developments in the treatment of gastric carcinomaQ41872774
Cancer statistics, 1990.Q43526438
Epidemiological research in stomach cancer: progress over the last ten yearsQ44089151
Etoposide, l-leucovorin and fluorouracil (ELF) regimen in metastatic gastric cancer: a phase II studyQ45237330
Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinomaQ45246256
Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer.Q53604465
Phase II Study of the Etoposide, Leucovorin and Fluorouracil Combination for Patients with Advanced Gastric Cancer Unsuitable for Aggressive ChemotherapyQ61628384
Etoposide, folinic acid, and 5-fluorouracil in carboplatin-pretreated patients with advanced gastric cancerQ67762042
Etoposide, doxorubicin, and cisplatin chemotherapy for advanced gastric adenocarcinoma: results of a phase II trialQ68075135
High dose folinic acid/etoposide/5-fluorouracil in advanced gastric cancer--a phase II study in elderly patients or patients with cardiac riskQ68797100
Comparison of CA 72-4 with CA 19-9 and carcinoembryonic antigen in the serodiagnostics of gastrointestinal malignanciesQ69796759
Clinical utility of CA 72-4 serum marker in the staging and immediate post-surgical management of gastric cancer patientsQ71226064
Etoposide, leucovorin and 5-fluorouracil in advanced gastric cancer: a phase II studyQ71985971
Correlation between positive CA 72-4 serum levels and lymph node involvement in patients with gastric carcinomaQ72309568
Efficacy of combined 5-fluorouracil and cisplatinum in advanced gastric carcinomas. A phase II trial with prognostic factor analysisQ72904323
The roles of chemotherapy and surgery in gastric carcinoma and the influence of prognostic factors on survivalQ73466014
CEA, CA 19-9, and CA-50 in monitoring gastric carcinomaQ73586888
Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of theQ74000577
Phase II study of the modified regimen of etoposide, leucovorin and 5-fluorouracil for patients with advanced gastric cancerQ77089988
P433issue1
P921main subjectfluorouracilQ238512
etoposideQ418817
P304page(s)43-53
P577publication date2002-01-01
P1433published inMedical OncologyQ2152666
P1476titleTreatment of advanced gastric cancer with etoposide, folinic acid, and fluorouracil in the clinical setting: efficacy of therapy and value of serum tumor markers
P478volume19

Reverse relations

cites work (P2860)
Q35181089Docetaxel as salvage therapy in highly pretreated and drug resistant gastrointestinal carcinomas
Q37277393Pancreaticoduodenectomy for advanced gastric cancer with pancreaticoduodenal region involvement
Q36616011Randomised phase II evaluation of irinotecan plus high-dose 5-fluorouracil and leucovorin (ILF) vs 5-fluorouracil, leucovorin, and etoposide (ELF) in untreated metastatic gastric cancer

Search more.